| Michael Edward Hellemn, MD | |
|
6124 W Parker Rd, Suite 534, Mob 3, Plano, TX 75093-8122 | |
| (972) 378-5250 | |
| (972) 378-6919 |
| Full Name | Michael Edward Hellemn |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 6124 W Parker Rd, Plano, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881887057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N0087 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Health Physicians Pllc | 7810237740 | 146 |
News Archive
Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.
› Verified 1 days ago
| Entity Name | Nuch Of Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760722334 PECOS PAC ID: 4880833698 Enrollment ID: O20130626000489 |
News Archive
Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.
› Verified 1 days ago
| Entity Name | Primary Health Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770048704 PECOS PAC ID: 7810237740 Enrollment ID: O20190312003418 |
News Archive
Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.
› Verified 1 days ago
| Entity Name | Ut East Texas Urgent Care Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356974281 PECOS PAC ID: 7517385388 Enrollment ID: O20200910000672 |
News Archive
Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.
› Verified 1 days ago
| Entity Name | Amazing Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477294510 PECOS PAC ID: 2365824265 Enrollment ID: O20220809000194 |
News Archive
Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Edward Hellemn, MD 3100 Independence Pkwy Ste 311, B 340, Plano, TX 75075-1997 Ph: (214) 517-7226 | Michael Edward Hellemn, MD 6124 W Parker Rd, Suite 534, Mob 3, Plano, TX 75093-8122 Ph: (972) 378-5250 |
News Archive
Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.
LEO Pharma today announced that it received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) for the treatment of psoriasis vulgaris in patients 18 years of age or older.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
People who are blind can now read more than just words, such as graphs and graphics, following the development of an affordable digital reading system by Curtin University researchers.
› Verified 1 days ago
Elaine C. Timm, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5425 W Spring Creek Pkwy, Suite 200, Plano, TX 75024 Phone: 972-599-9600 Fax: 972-599-9696 | |
Matthew Garrett Weyenberg, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5425 W Spring Creek Pkwy, Suite 200, Plano, TX 75024 Phone: 972-599-9600 Fax: 972-599-9696 | |
Dr. Lorenzo Fredi Perez, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3821 W Spring Creek Pkwy, Plano, TX 75023 Phone: 972-599-0077 | |
Dr. Mahdi M Awwad, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4010 W Park Blvd, Plano, TX 75093 Phone: 724-824-2919 | |
Dr. Gregory Alan Ennis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5655 West Spring Creek Pkwy, Suite 200, Plano, TX 75024 Phone: 972-599-9600 Fax: 972-599-9696 | |
Adeel Zafar Qureshi, Family Medicine Medicare: Medicare Enrolled Practice Location: 6839 Communications Pkwy, Plano, TX 75024 Phone: 972-733-7242 | |
Dr. Ami R Shah, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6124 West Parker Road, Mob Iii Suite 234, Plano, TX 75093 Phone: 972-981-7500 Fax: 972-981-3600 |